News - Hi-Tech Pharmacal


Current filters:

Hi-Tech Pharmacal

Popular Filters

Akorn buy of Hi-Tech Pharmacal delayed by FTC request


In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Akorn buys rival generic drugmaker for $640 million


USA-based generics drugmaker Akorn (Nasdaq: AKRX) has bought rival generic drugmaker Hi-Tech Pharmacal…

AkornGenericsHi-Tech PharmacalMergers & AcquisitionsNorth America

Hi-Tech Pharmacal gains rights to the Cormax brand from Watson


Hi-Tech Pharmacal (Nasdaq: HITK) says it has signed a definitive agreement under which it has acquired…

CormaxDermatologicalsGenericsHi-Tech PharmacalLicensingWatson Pharmaceuticals

Back to top